HealthStream Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

HealthStream wird ein Gewinn- und Umsatzwachstum von 5.3% bzw. 6.1% pro Jahr prognostiziert, während der Gewinn pro Aktie um 3.9% pro Jahr wachsen soll.

Wichtige Informationen

5.3%

Wachstumsrate der Gewinne

3.9%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	30.9%
Wachstumsrate der Einnahmen	6.1%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	20 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 24

Recent updates

HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit

Aug 08

We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease

Jul 17

HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 24

HealthStream GAAP EPS of $0.10 beats by $0.05, revenue of $65.64M misses by $0.63M

Jul 25

HealthStream's (NASDAQ:HSTM) Returns Have Hit A Wall

Jun 24

A Look At The Fair Value Of HealthStream, Inc. (NASDAQ:HSTM)

Jun 04

We Discuss Why HealthStream, Inc.'s (NASDAQ:HSTM) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

May 14

HealthStream up after-hours after earnings beat; raises FY 2021 guidance

Apr 26

Returns At HealthStream (NASDAQ:HSTM) Appear To Be Weighed Down

Apr 08

Has HealthStream, Inc. (NASDAQ:HSTM) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Mar 21

Have HealthStream, Inc. (NASDAQ:HSTM) Insiders Been Selling Their Stock?

Mar 03

Analysts Are Updating Their HealthStream, Inc. (NASDAQ:HSTM) Estimates After Its Full-Year Results

Feb 24

Calculating The Intrinsic Value Of HealthStream, Inc. (NASDAQ:HSTM)

Feb 22

Does HealthStream's (NASDAQ:HSTM) Share Price Gain of 19% Match Its Business Performance?

Jan 27

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:HSTM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	330	N/A	34	N/A	1
12/31/2025	308	19	32	67	6
12/31/2024	292	18	26	56	6
6/30/2024	285	18	38	66	N/A
3/31/2024	283	18	37	64	N/A
12/31/2023	279	15	36	64	N/A
9/30/2023	277	13	31	58	N/A
6/30/2023	274	13	22	49	N/A
3/31/2023	270	12	24	51	N/A
12/31/2022	267	12	26	51	N/A
9/30/2022	263	9	24	49	N/A
6/30/2022	259	7	20	46	N/A
3/31/2022	259	6	19	44	N/A
12/31/2021	257	6	17	42	N/A
9/30/2021	254	7	18	42	N/A
6/30/2021	251	8	24	47	N/A
3/31/2021	247	9	28	49	N/A
12/31/2020	245	14	17	36	N/A
9/30/2020	246	17	26	44	N/A
6/30/2020	247	18	25	43	N/A
3/31/2020	250	17	30	56	N/A
12/31/2019	254	14	29	66	N/A
9/30/2019	251	14	28	67	N/A
6/30/2019	249	13	27	65	N/A
3/31/2019	242	14	20	51	N/A
12/31/2018	232	13	25	43	N/A
9/30/2018	227	13	25	40	N/A
6/30/2018	222	12	24	39	N/A
3/31/2018	218	11	N/A	39	N/A
12/31/2017	215	9	N/A	47	N/A
9/30/2017	218	5	N/A	45	N/A
6/30/2017	222	5	N/A	47	N/A
3/31/2017	224	4	N/A	35	N/A
12/31/2016	192	5	N/A	24	N/A
9/30/2016	223	6	N/A	24	N/A
6/30/2016	219	7	N/A	16	N/A
3/31/2016	216	7	N/A	32	N/A
12/31/2015	209	9	N/A	35	N/A
9/30/2015	198	9	N/A	31	N/A
6/30/2015	189	10	N/A	31	N/A
3/31/2015	179	11	N/A	34	N/A
12/31/2014	171	10	N/A	34	N/A
9/30/2014	162	10	N/A	33	N/A
6/30/2014	152	8	N/A	38	N/A
3/31/2014	141	8	N/A	32	N/A
12/31/2013	132	8	N/A	27	N/A
9/30/2013	123	8	N/A	30	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HSTMDas prognostizierte Gewinnwachstum (4.9% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: HSTMDie Erträge des Unternehmens (1.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).

Hohe Wachstumserträge: HSTMDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: HSTMDie Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: HSTMDie Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von HSTM in 3 Jahren voraussichtlich hoch sein wird

HealthStream Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

HealthStream, Inc. Reaffirms Earnings Guidance for 2024

Price target increased by 9.2% to US$31.67

HealthStream, Inc. Updates Earnings Guidance for the Year 2023

Healthstream, Inc. Provides Revenue Guidance for the Year 2023

Consensus EPS estimates increase by 20%, revenue downgraded

Recent updates

HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.028 per share

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Healthstream, Inc. Approves Quarterly Cash Dividend, Payable on August 16, 2024

We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease

HealthStream, Inc. to Report Q2, 2024 Results on Jul 22, 2024

Upcoming dividend of US$0.028 per share

HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthStream, Inc. Reaffirms Earnings Guidance for 2024

HealthStream, Inc. to Report Q1, 2024 Results on Apr 22, 2024

HealthStream, Inc., Annual General Meeting, May 30, 2024

Upcoming dividend of US$0.028 per share

Insider recently sold US$184k worth of stock

HealthStream, Inc. Announces Increases Quarterly Dividend, Payable on March 22, 2024

HealthStream, Inc. to Report Q4, 2023 Results on Feb 19, 2024

Price target increased by 9.2% to US$31.67

Upcoming dividend of US$0.025 per share at 0.4% yield

Now 21% undervalued

New minor risk - Earnings quality

HealthStream, Inc. Updates Earnings Guidance for the Year 2023

HealthStream, Inc. to Report Q3, 2023 Results on Oct 23, 2023

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $10 million worth of its shares.

Upcoming dividend of US$0.025 per share at 0.5% yield

Second quarter 2023 earnings: EPS exceeds analyst expectations

Healthstream, Inc. Provides Revenue Guidance for the Year 2023

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

Upcoming dividend of US$0.025 per share at 0.4% yield

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold US$378k worth of stock

First quarter 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of US$0.025 per share at 0.4% yield

Insider exercised options and sold US$121k worth of stock

Consensus EPS estimates increase by 20%, revenue downgraded

Independent Director recently sold US$85k worth of stock

Full year 2022 earnings: EPS exceeds analyst expectations

HealthStream, Inc. to Report Q4, 2022 Results on Feb 20, 2023

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

HealthStream, Inc. to Report Q3, 2022 Results on Oct 24, 2022

Independent Director recently sold US$121k worth of stock

Healthstream, Inc. Provides Earnings Guidance for the Year 2022

Second quarter 2022 earnings: EPS exceeds analyst expectations

HealthStream GAAP EPS of $0.10 beats by $0.05, revenue of $65.64M misses by $0.63M

HealthStream, Inc. to Report Q2, 2022 Results on Jul 25, 2022

HealthStream's (NASDAQ:HSTM) Returns Have Hit A Wall

HealthStream, Inc. (NasdaqGS:HSTM) acquired the remaining 80% stake in CloudCME, LLC for $8.1 million.

Consensus forecasts updated

Price target decreased to US$29.00

Insufficient new directors

HealthStream, Inc. Reiterates Earnings Guidance for the Fiscal Year 2022

HealthStream, Inc. to Report Q1, 2022 Results on Apr 25, 2022

HealthStream, Inc., Annual General Meeting, May 26, 2022

Senior VP & President of VerityStream exercised options and sold US$121k worth of stock

Consensus EPS estimates fall by 13%

Price target decreased to US$29.00

Full year 2021 earnings: EPS misses analyst expectations

HealthStream, Inc. Provides Earnings Guidance for the Full Year 2022

HealthStream, Inc. to Report Q4, 2021 Results on Feb 21, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Rievent Technologies for $4 million.

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $20 million worth of its shares.

Independent Director recently bought US$100k worth of stock

Third quarter 2021 earnings released: EPS US$0.048 (vs US$0.082 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.077 (vs US$0.11 in 2Q 2020)

Price target increased to US$31.00

Consensus EPS estimates increase to US$0.07

A Look At The Fair Value Of HealthStream, Inc. (NASDAQ:HSTM)